BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7583777)

  • 1. Cyclosporin A promotes nuclear transfer of a cytoplasmic progesterone receptor mutant.
    Jung-Testas I; Lebeau MC; Catelli MG; Baulieu EE
    C R Acad Sci III; 1995 Aug; 318(8):873-8. PubMed ID: 7583777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular distribution of a cytoplasmic progesterone receptor mutant and of immunophilins cyclophilin 40 and FKBP59: effects of cyclosporin A, of various metabolic inhibitors and of several culture conditions.
    Lebeau MC; Jung-Testas I; Baulieu EE
    J Steroid Biochem Mol Biol; 1999; 70(4-6):219-28. PubMed ID: 10622411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling.
    Hafizi S; Mordi VN; Andersson KM; Chester AH; Yacoub MH
    Vascul Pharmacol; 2004; 41(4-5):167-76. PubMed ID: 15607500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of immunosuppressants FK506 and rapamycin on the function of progesterone receptor: protein "p59-HBI", intersection between immunology and endocrinology?].
    Renoir JM; Radanyi C; Baulieu EE
    C R Acad Sci III; 1992; 315(11):421-8. PubMed ID: 1284044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin.
    Bierer BE
    Proc Assoc Am Physicians; 1995 Apr; 107(1):28-40. PubMed ID: 8630742
    [No Abstract]   [Full Text] [Related]  

  • 6. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA; Bird IA; Almawi WY; Rieder MJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of cell surface sodium channels by cyclosporin A, FK506, and rapamycin in adrenal chromaffin cells.
    Shiraishi S; Yanagita T; Kobayashi H; Uezono Y; Yokoo H; Minami SI; Takasaki M; Wada A
    J Pharmacol Exp Ther; 2001 May; 297(2):657-65. PubMed ID: 11303055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of initial subcellular localization of progesterone receptor on import kinetics and transcriptional activity.
    Li H; Fidler ML; Lim CS
    Mol Pharm; 2005; 2(6):509-18. PubMed ID: 16323958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the progesterone receptor with binding proteins for FK506 and cyclosporin A.
    Milad M; Sullivan W; Diehl E; Altmann M; Nordeen S; Edwards DP; Toft DO
    Mol Endocrinol; 1995 Jul; 9(7):838-47. PubMed ID: 7476967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modes of action of FK506, cyclosporin A, and rapamycin.
    Morris R
    Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
    [No Abstract]   [Full Text] [Related]  

  • 11. A role for calcineurin in degranulation of murine cytotoxic T lymphocytes.
    Dutz JP; Fruman DA; Burakoff SJ; Bierer BE
    J Immunol; 1993 Apr; 150(7):2591-8. PubMed ID: 7681074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
    Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I
    Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cyclosporin and tacrolimus (FK506) on the antigen-induced mediator release, membrane potential and 86Rb+/K+ and Ca2+ fluxes in the RBL-2H3 cell line.
    Narenjkar J; Assem el-SK; Wan BY; Marsh S; Ezeamuzie CI
    Int Immunopharmacol; 2006 May; 6(5):742-9. PubMed ID: 16546704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of action of the new immunosuppressants: cyclosporin A, FK 506 and rapamycin].
    Rondeau E
    Nephrologie; 1992; 13(3):137. PubMed ID: 1379348
    [No Abstract]   [Full Text] [Related]  

  • 15. Osteoblastic differentiation is enhanced by rapamycin in rat osteoblast-like osteosarcoma (ROS 17/2.8) cells.
    Ogawa T; Tokuda M; Tomizawa K; Matsui H; Itano T; Konishi R; Nagahata S; Hatase O
    Biochem Biophys Res Commun; 1998 Aug; 249(1):226-30. PubMed ID: 9705862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of immunosuppressive drugs (CsA, FK 506, rapamycin) on the kidney microsomal cytochrome P-450 system in the rat.
    Yoshimura R; Yoshimura N; Ohmachi T; Nakatani T; Ohyama A; Miyao Y; Yamamoto K; Kishimoto T
    Transplant Proc; 1994 Oct; 26(5):2890. PubMed ID: 7524223
    [No Abstract]   [Full Text] [Related]  

  • 17. Dentritic cell derived IL-18 production is inhibited by rapamycin and sanglifehrin A, but not cyclosporine A.
    Ko H; Hambly BD; Eris JM; Levidiotis V; Wyburn K; Wu H; Chadban SJ; Yin JL
    Transpl Immunol; 2008 Nov; 20(1-2):99-105. PubMed ID: 18662782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tacrolimus and cyclosporine A on suppression of albumin secretion induced by inflammatory cytokines in cultured human hepatocytes.
    Li Y; Liu FY; Liu ZH; Huang YF; Li LS; Zhang X; Peng YM
    Inflamm Res; 2006 May; 55(5):216-20. PubMed ID: 16830109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin A, rapamycin and FK506 decrease prolactin release from rat pituitary cells in primary culture.
    Wera S; Zheng L; Hooghe-Peters EL; Belayew A; Martial JA; Velkeniers B
    Endocr Res; 1995 Aug; 21(3):623-33. PubMed ID: 7588431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressants inhibit hormone-stimulated Mg2+ uptake in mouse distal convoluted tubule cells.
    Kim SJ; Kang HS; Jeong CW; Park SY; Kim IS; Kim NS; Kim SZ; Kwak YG; Kim JS; Quamme GA
    Biochem Biophys Res Commun; 2006 Mar; 341(3):742-8. PubMed ID: 16438932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.